News Focus
News Focus
icon url

tredenwater2

07/07/22 6:31 PM

#365541 RE: Steady_T #365530

So where are all of these costs you expect going to come from that will require massive dilution to pay for?



Spot on and this point has been made many times. Rare disease revenue and any upfront partnership money (if needed or desired) will pad the war chest. Dr. Missling has us in a good negotiating spot instead of 80-90% of other bio’s that get hornswaggelled into giving up their IP prior to approval. If and when the next time we run into the $30’s - $50’s I can see Dr Missling selling another 1-2 million shares and I wouldnt fault him.

I bet this speculation on massive dillution comes up at least 10 more times before TLD readout.
icon url

boi568

07/07/22 6:55 PM

#365545 RE: Steady_T #365530

It is at best only a fantasy.
icon url

ExtremelyBullishZig

07/07/22 10:34 PM

#365557 RE: Steady_T #365530

Yes, because that is how the real world works...Biogen...has zero expenses right? Partnerships are huge forms of dilution. They may have to create 200,000,000 shares out of thin air just to fork it over to the partner(s).

Who the hell refers to Anavex growth due to Rett...that is just for a distraction...obviously my comment has to do with AD and the countless cures that thus board assumes Anavex will provide. A2-73 probably cure world hunger too, right. Also, why do you keep trusting what Missiling says...the company will be sold anyhow.

But let me guess...in your view Anavex stops after the current list of indications and doesn't grow their company in adding multiple departments, etc.? How do you become big pharma without expanding? It's not a shell company. Show me a large corporation that uses only their revenue to sustain their business. You are living on fantasy island. That is what big business is about...taking advantage of all of the money coming in from manufacturing shares. Just like printing money for the hell of it...

Let me guess, you think Missiling is a great ethical guy, so he would never run a business like the rest of the world runs businesses.